
Sign up to save your podcasts
Or
Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.
5
4949 ratings
Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.
6,069 Listeners
14,149 Listeners
24 Listeners
1,777 Listeners
9,040 Listeners
932 Listeners
55,874 Listeners
5,279 Listeners
5,425 Listeners
2 Listeners
2,209 Listeners
3,261 Listeners
450 Listeners
971 Listeners
5 Listeners